Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Patent
1995-06-06
1997-12-02
Hutzell, Paula K.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
435328, 435335, 5303873, 53038823, A61K 39395, C12P 2108, C07K 1600
Patent
active
056933231
ABSTRACT:
Chimeric, humanized and other IL-5 mAbs, derived from high affinity neutralizing mAbs, pharmaceutical compositions containing same, methods of treatment and diagnostics are provided.
REFERENCES:
patent: 5096704 (1992-03-01), Coffman et al.
Collet et al., PNAS USA 89: 10026-10030, 1992.
Clark et al. in:"Enzyme Immunoassay", Maggio Ed., CRC Press 1980, pp. 167-179.
Kabat, "Sequences of Proteins of Immunological Interest", NIN PUBL No. 91-3242, 1991 pp. 128, 318.
Ames, Jr. Robert S.
Appelbaum Edward Robert
Chaiken Irwin M.
Cook Richard M.
Gross Mitchell Stuart
Eagle Alissa M.
Hutzell Paula K.
Kinzig Charles M.
Lentz Edward T.
Navarro Mark
LandOfFree
Recombinant IL-5 antagonists useful in treatment of IL-5 mediate does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant IL-5 antagonists useful in treatment of IL-5 mediate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant IL-5 antagonists useful in treatment of IL-5 mediate will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-799059